Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Stripe is a payment service provider that accepts credit cards, digital wallets and many other payment methods. Many, or all, of the products featured on this page are from our advertising partners ...
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
Welcome to this afternoon session with Recursion. My name is Andrew Pucher. I'm part of the Healthcare Investment Banking team, and I'm joined by Ben Taylor, CFO of Recursion; and Sara Sherman, Head ...
Jake Goldenfein receives funding from the Australian Research Council Centre of Excellence for Automated Decision-Making and Society (ADM+S). This research was conducted with assistance from the ...
We may earn commission from links on this page, but we only recommend products we love. Promise. If you haven’t heard of Hinge, where have you been?! With 30 million users, it’s one of the largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback